Patent · US Active

Methods of treating pediatric cancers

US10588908B2 · kind B2 · utility

2Cited by
73References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 3, 2018
Grant dateMar 17, 2020
Priority date
Expiry dateJan 3, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating a pediatric cancer in a subject in need thereof. The method includes administering to the subject a therapeutically effective amount of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, or a pharmaceutically acceptable salt thereof, or a combination thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.